Takeda Posts Slightly Higher Net

Takeda Pharmaceutical posted a 5.9% rise in full-year net profit, but said it expects earnings to slump in the current year following its recent $8.8 billion purchase of a U.S. biotechnology company.

Sphere: Related Content

Leave a Reply

« Dresdner Drags Allianz Results Lower Sotheby’s Posts Loss Amid Revenue Drop »